Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

Evidence reviews

The following documents contain the evidence that was used to develop the 2023 recommendations:

• Diagnosing VTE in people with COVID-19
• PERC supporting information

The following documents contain the evidence that was used to develop the 2020 recommendations:

• D-dimer testing
• Use of the pulmonary embolism rule-out criteria
• Investigations for cancer
• Pharmacological treatment
• Outpatient treatment for low-risk pulmonary embolism
• Duration of pharmacological treatment
• Economic modelling report on pharmacological treatment
• Inferior vena caval filters

See the guideline scope for more information about why we decided to update this guideline in 2020.

Evidence for recommendations before 2020 can be found in the 2015 full guideline addendum and the 2012 full guideline:

• Full guideline addendum - November 2015
• Full guideline - June 2012